Taysha Gene Therapies
TSHA----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Taysha Gene Therapies(TSHA) predict that the EBIT is -43.49 M (-103%), Miss estimate;the EPS is -0.12 (-50%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B67.06%
----
EBITMiss expectations
-0.04B103.01%
-0.04B63.77%
-0.01B39.24%
EPSMiss expectations
-0.1250.00%
-0.095819.79%
-0.024230.21%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf